##gff-version 3
##sequence-region Q9H902 1 201
Q9H902	UniProtKB	Chain	1	201	.	.	.	ID=PRO_0000101821;Note=Receptor expression-enhancing protein 1	
Q9H902	UniProtKB	Transmembrane	1	21	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9H902	UniProtKB	Transmembrane	35	55	.	.	.	Note=Helical;Ontology_term=ECO:0000255;evidence=ECO:0000255	
Q9H902	UniProtKB	Compositional bias	170	173	.	.	.	Note=Poly-Pro	
Q9H902	UniProtKB	Modified residue	152	152	.	.	.	Note=Phosphoserine;Ontology_term=ECO:0000244,ECO:0000244;evidence=ECO:0000244|PubMed:19690332,ECO:0000244|PubMed:23186163;Dbxref=PMID:19690332,PMID:23186163	
Q9H902	UniProtKB	Alternative sequence	1	35	.	.	.	ID=VSP_042573;Note=In isoform 2. MVSWIISRLVVLIFGTLYPAYYSYKAVKSKDIKEY->MDHLQAGG;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9H902	UniProtKB	Alternative sequence	1	11	.	.	.	ID=VSP_043251;Note=In isoform 3. MVSWIISRLVV->MQKVLSNGQTEEVRSGSR;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9H902	UniProtKB	Alternative sequence	62	201	.	.	.	ID=VSP_043252;Note=In isoform 4. FPFYYELKIAFVAWLLSPYTKGSSLLYRKFVHPTLSSKEKEIDDCLVQAKDRSYDALVHFGKRGLNVAATAAVMAASKGQGALSERLRSFSMQDLTTIRGDGAPAPSGPPPPGSGRASGKHGQPKMSRSASESASSSGTA->DRVPYRRDCGASACRTSPPSGETAPLLPRAPHHRGLGGPAANTASLRCPGVLLRALAAQAPPRILRSRFRKKSTSSSATETT;Ontology_term=ECO:0000303;evidence=ECO:0000303|PubMed:14702039;Dbxref=PMID:14702039	
Q9H902	UniProtKB	Natural variant	19	19	.	.	.	ID=VAR_067265;Note=In SPG31%3B impairs normal ER-targeting. P->L;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21618648,ECO:0000269|PubMed:24478229;Dbxref=PMID:21618648,PMID:24478229	
Q9H902	UniProtKB	Natural variant	19	19	.	.	.	ID=VAR_072609;Note=In SPG31%3B impairs normal ER-targeting. P->R;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:24478229;Dbxref=dbSNP:rs1060503496,PMID:24478229	
Q9H902	UniProtKB	Natural variant	20	20	.	.	.	ID=VAR_027351;Note=In SPG31%3B loss of function mutation%3B shows severely altered localization to numerous punctate small structures throughout the cytoplasm%3B does not localize to the endoplasmic reticulum%3B impairs normal ER tageting. A->E;Ontology_term=ECO:0000269,ECO:0000269,ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:16826527,ECO:0000269|PubMed:20718791,ECO:0000269|PubMed:22703882,ECO:0000269|PubMed:24478229;Dbxref=dbSNP:rs121918262,PMID:16826527,PMID:20718791,PMID:22703882,PMID:24478229	
Q9H902	UniProtKB	Natural variant	23	23	.	.	.	ID=VAR_067266;Note=In SPG31%3B impairs normal ER-tageting. S->F;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21618648,ECO:0000269|PubMed:24478229;Dbxref=PMID:21618648,PMID:24478229	
Q9H902	UniProtKB	Natural variant	42	42	.	.	.	ID=VAR_067267;Note=In SPG31%3B impairs normal ER-tageting. W->R;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21618648,ECO:0000269|PubMed:24478229;Dbxref=PMID:21618648,PMID:24478229	
Q9H902	UniProtKB	Natural variant	55	55	.	.	.	ID=VAR_072610;Note=In SPG31%3B unknown pathological significance%3B does not impair normal ER-targeting. T->K;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:18644145,ECO:0000269|PubMed:24478229;Dbxref=PMID:18644145,PMID:24478229	
Q9H902	UniProtKB	Natural variant	56	56	.	.	.	ID=VAR_067268;Note=In SPG31%3B unknown pathological significance%3B does not impair normal ER-tageting. D->N;Ontology_term=ECO:0000269,ECO:0000269;evidence=ECO:0000269|PubMed:21618648,ECO:0000269|PubMed:24478229;Dbxref=dbSNP:rs1060503493,PMID:21618648,PMID:24478229	
Q9H902	UniProtKB	Natural variant	107	107	.	.	.	ID=VAR_072611;Note=In SPG31. L->P;Ontology_term=ECO:0000269;evidence=ECO:0000269|PubMed:18644145;Dbxref=PMID:18644145	
